Cerebral myogenic reactivity and blood flow in type 2 diabetic rats: Role of peroxynitrite in hypoxia-mediated loss of myogenic tone

Journal of Pharmacology and Experimental Therapeutics

Volumn 342, Issue 2, 2012, Pages 407-415

  Kelly Cobbs, Aisha I ^a   Prakash, Roshini ^b   Coucha, Maha ^a   Knight, Robert A ^c   Li, Weiguo ^a   Ogbi, Safia N ^a   Johnson, Maribeth ^a   Ergul, Adviye ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; F ACTIN; G ACTIN; PEROXYNITRITE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; HYPEREMIA; HYPOXIA; INSULA; MALE; MIDDLE CEREBRAL ARTERY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; SOMATOSENSORY CORTEX; VASODILATATION;

ACTINS; ANIMALS; CELL HYPOXIA; CEREBROVASCULAR CIRCULATION; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HYPEREMIA; MALE; METALLOPORPHYRINS; MIDDLE CEREBRAL ARTERY; MUSCLE, SMOOTH, VASCULAR; PEROXYNITROUS ACID; RATS; RATS, WISTAR; TYROSINE;

EID: 84864142878     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.191296     Document Type: Article

References (59)

1. Abdelsaid MA, Pillai BA, Matragoon S, Prakash R, Al-Shabrawey M, and El-Remessy AB (2010) Early intervention of tyrosine nitration prevents vasoobliteration and neovascularization in ischemic retinopathy. J Pharmacol Exp Ther 332:125-134.
2. Al-Saeedi FJ (2008) Perfusion scanning using 99mTc-HMPAO detects early cerebrovascular changes in the diabetic rat. BMC Med Phys 8:1.
3. Bagi Z, Toth E, Koller A, and Kaley G (2004) Microvascular dysfunction after transient high glucose is caused by superoxide-dependent reduction in the bio-availability of NO and BH(4). Am J Physiol Heart Circ Physiol 287:H626-H633. (Pubitemid 38955293)
4. Carlsson CM (2010) Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease. J Alzheimers Dis 20:711-722.
5. Cipolla MJ and Curry AB (2002) Middle cerebral artery function after stroke: the threshold duration of reperfusion for myogenic activity. Stroke 33:2094-2099. (Pubitemid 34840074)
6. Cipolla MJ and Osol G (1998) Vascular smooth muscle actin cytoskeleton in cerebral artery forced dilatation. Stroke 29:1223-1228. (Pubitemid 28265481)
7. Cipolla MJ, McCall AL, Lessov N, and Porter JM (1997a) Reperfusion decreases myogenic reactivity and alters middle cerebral artery function after focal cerebral ischemia in rats. Stroke 28:176-180. (Pubitemid 27039482)
8. Cipolla MJ, Porter JM, and Osol G (1997b) High glucose concentrations dilate cerebral arteries and diminish myogenic tone through an endothelial mechanism. Stroke 28:405-410; discussion 410-411.
9. Cipolla MJ, Lessov N, Hammer ES, and Curry AB (2001) Threshold duration of ischemia for myogenic tone in middle cerebral arteries: effect on vascular smooth muscle actin. Stroke 32:1658-1664. (Pubitemid 32631921)
10. Clements MK, Siemsen DW, Swain SD, Hanson AJ, Nelson-Overton LK, Rohn TT, and Quinn MT (2003) Inhibition of actin polymerization by peroxynitrite modulates neutrophil functional responses. J Leukoc Biol 73:344-355. (Pubitemid 36790850)
11. Dailianis S, Patetsini E, and Kaloyianni M (2009) The role of signalling molecules on actin glutathionylation and protein carbonylation induced by cadmium in haemocytes of mussel Mytilus galloprovincialis (Lmk). J Exp Biol 212:3612-3620.
12. Detre JA, Leigh JS, Williams DS, and Koretsky AP (1992) Perfusion imaging. Magn Reson Med 23:37-45.
13. Didion SP, Lynch CM, Baumbach GL, and Faraci FM (2005) Impaired endothelium-dependent responses and enhanced influence of Rho-kinase in cerebral arterioles in type II diabetes. Stroke 36:342-347. (Pubitemid 40170820)
14. Dixon WT, Du LN, Faul DD, Gado M, and Rossnick S (1986) Projection angiograms of blood labeled by adiabatic fast passage. Magn Reson Med 3:454-462. (Pubitemid 16092680)
15. Dohmen C, Bosche B, Graf R, Reithmeier T, Ernestus RI, Brinker G, Sobesky J, and Heiss WD (2007) Identification and clinical impact of impaired cerebrovascular autoregulation in patients with malignant middle cerebral artery infarction. Stroke 38:56-61. (Pubitemid 46035606)
16. Drake CT and Iadecola C (2007) The role of neuronal signaling in controlling cerebral blood flow. Brain Lang 102:141-152. (Pubitemid 46962667)
17. Duckrow RB, Beard DC, and Brennan RW (1987) Regional cerebral blood flow decreases during chronic and acute hyperglycemia. Stroke 18:52-58. (Pubitemid 17016685)
18. El-Remessy AB, Tawfik HE, Matragoon S, Pillai B, Caldwell RB, and Caldwell RW (2010) Peroxynitrite mediates diabetes-induced endothelial dysfunction: possible role of Rho kinase activation. Exp Diabetes Res 2010:247861.
19. Elgebaly MM, Portik-Dobos V, Sachidanandam K, Rychly D, Malcom D, Johnson MH, and Ergul A (2007) Differential effects of ET(A) and ET(B) receptor antagonism on oxidative stress in type 2 diabetes. Vascul Pharmacol 47:125-130. (Pubitemid 47095454)
20. Elgebaly MM, Kelly A, Harris AK, Elewa H, Portik-Dobos V, Ketsawatsomkron P, Marrero M, and Ergul A (2008) Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes: role of endothelin-1. Can J Physiol Pharmacol 86:358-364. (Pubitemid 351821129)
21. Elgebaly MM, Prakash R, Li W, Ogbi S, Johnson MH, Mezzetti EM, Fagan SC, and Ergul A (2010) Vascular protection in diabetic stroke: role of matrix metalloprotease-dependent vascular remodeling. J Cereb Blood Flow Metab 30:1928-1938.
22. Faraci FM and Heistad DD (1990) Regulation of large cerebral arteries and cerebral microvascular pressure. Circ Res 66:8-17. (Pubitemid 20033921)
23. Fowler M (2008) Microvascular and macrovascular complications of diabetes. Clin Diabetes 26:77-82.
24. Fukuyama N, Takizawa S, Ishida H, Hoshiai K, Shinohara Y, and Nakazawa H (1998) Peroxynitrite formation in focal cerebral ischemia-reperfusion in rats occurs predominantly in the peri-infarct region. J Cereb Blood Flow Metab 18:123-129. (Pubitemid 28082507)
25. Girouard H and Iadecola C (2006) Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J Appl Physiol 100:328-335. (Pubitemid 43671125)
26. Goto Y, Kakizaki M, and Masaki N (1976) Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J Exp Med 119:85-90.
27. Gü rsoy-Ozdemir Y, Can A, and Dalkara T (2004) Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke 35:1449-1453.
28. Harris AK, Hutchinson JR, Sachidanandam K, Johnson MH, Dorrance AM, Stepp DW, Fagan SC, and Ergul A (2005) Type 2 diabetes causes remodeling of cerebro-vasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1. Diabetes 54:2638-2644. (Pubitemid 41233585)
29. Harris AK, Elgebaly MM, Li W, Sachidanandam K, and Ergul A (2008) Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes. Am J Physiol Regul Integr Comp Physiol 294:R1213-R1219. (Pubitemid 351490640)
30. Hasselbalch SG, Knudsen GM, Capaldo B, Postiglione A, and Paulson OB (2001) Blood-brain barrier transport and brain metabolism of glucose during acute hyperglycemia in humans. J Clin Endocrinol Metab 86:1986-1990. (Pubitemid 32472909)
31. Humpel C (2011) Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease? Exp Gerontol 46:225-232.
32. Iadecola C (2004) Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 5:347-360.
33. Jarajapu YP, Guberski DL, Grant MB, and Knot HJ (2008) Myogenic tone and reactivity of cerebral arteries in type II diabetic BBZDR/Wor rat. Eur J Pharmacol 579:298-307.
34. Jiménez-Altayó F, Caracuel L, Pérez-Asensio FJ, Martínez-Revelles S, Messeguer A, Planas AM, and Vila E (2009) Participation of oxidative stress on rat middle cerebral artery changes induced by focal cerebral ischemia: beneficial effects of 3,4-dihydro-6-hydroxy-7- methoxy-2,2-dimethyl-1(2H)-benzopyran (CR-6). J Pharmacol Exp Ther 331:429-436.
35. Johansson M and Lundberg M (2007) Glutathionylation of beta-actin via a cysteinyl sulfenic acid intermediary. BMC Biochem 8:26.
36. Johnson PC (1964) Review of previous studies and current theories of autoregulation. Circ Res 15 (Suppl):2-9.
37. Kaarisalo MM, Räihä I, Sivenius J, Immonen-Räihä P, Lehtonen A, Sarti C, Mähönen M, Torppa J, Tuomilehto J, and Salomaa V (2005) Diabetes worsens the outcome of acute ischemic stroke. Diabetes Res Clin Pract 69:293-298. (Pubitemid 41140110)
38. Káplá r M, Paragh G, Erdei A, Csongrá di E, Varga E, Garai I, Szabados L, Galuska L, and Varga J (2009) Changes in cerebral blood flow detected by SPECT in type 1 and type 2 diabetic patients. J Nucl Med 50:1993-1998.
39. Knight RA, Barker PB, Fagan SC, Li Y, Jacobs MA, and Welch KM (1998) Prediction of impending hemorrhagic transformation in ischemic stroke using magnetic resonance imaging in rats. Stroke 29:144-151. (Pubitemid 28046957)
40. Lecrux C and Hamel E (2011) The neurovascular unit in brain function and disease. Acta Physiol (Oxf) 203:47-59.
41. Li W, Prakash R, Kelly-Cobbs AI, Ogbi S, Kozak A, El-Remessy AB, Schreihofer DA, Fagan SC, and Ergul A (2010) Adaptive cerebral neovascularization in a model of type 2 diabetes: relevance to focal cerebral ischemia. Diabetes 59:228-235.
42. Lynch FM, Austin C, Heagerty AM, and Izzard AS (2006) Adenosine- and hypoxia-induced dilation of human coronary resistance arteries: evidence against the involvement of K(ATP) channels. Br J Pharmacol 147:455-458. (Pubitemid 43292288)
43. Maneen MJ and Cipolla MJ (2007) Peroxynitrite diminishes myogenic tone in cerebral arteries: role of nitrotyrosine and F-actin. Am J Physiol Heart Circ Physiol 292:H1042-H1050.
44. Maneen MJ, Hannah R, Vitullo L, DeLance N, and Cipolla MJ (2006) Peroxynitrite diminishes myogenic activity and is associated with decreased vascular smooth muscle F-actin in rat posterior cerebral arteries. Stroke 37:894-899. (Pubitemid 43731928)
45. Mayhan WG (1993) Cerebral circulation during diabetes mellitus. Pharmacol Ther 57:377-391.
46. Neil HA, Gale EA, Hamilton SJ, Lopez-Espinoza I, Kaura R, and McCarthy ST (1987) Cerebral blood flow increases during insulin-induced hypoglycaemia in type 1 (insulin-dependent) diabetic patients and control subjects. Diabetologia 30:305-309. (Pubitemid 17083698)
47. Nicolakakis N, Aboulkassim T, Ongali B, Lecrux C, Fernandes P, Rosa-Neto P, Tong XK, and Hamel E (2008) Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist. J Neurosci 28:9287-9296.
48. Ohara T, Doi Y, Ninomiya T, Hirakawa Y, Hata J, Iwaki T, Kanba S, and Kiyohara Y (2011) Glucose tolerance status and risk of dementia in the community: the Hisayama study. Neurology 77:1126-1134.
49. Oizumi XS, Akisaki T, Kouta Y, Song XZ, Takata T, Kondoh T, Umetani K, Hirano M, Yamasaki K, Kohmura E, et al. (2006) Impaired response of perforating arteries to hypercapnia in chronic hyperglycemia. Kobe J Med Sci 52:27-35.
50. Osol G, Laher I, and Cipolla M (1991) Protein kinase C modulates basal myogenic tone in resistance arteries from the cerebral circulation. Circ Res 68:359-367.
51. Pérez-Asensio FJ, de la Rosa X, Jiménez-Altayó F, Gorina R, Martínez E, Messeguer A, Vila E, Chamorro A, and Planas AM (2010) Antioxidant CR-6 protects against reperfusion injury after a transient episode of focal brain ischemia in rats. J Cereb Blood Flow Metab 30:638-652.
52. Portik-Dobos V, Harris AK, Song W, Hutchinson J, Johnson MH, Imig JD, Pollock DM, and Ergul A (2006) Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes. Am J Physiol Regul Integr Comp Physiol 290:R435-R441.
53. Reusch JE (2003) Diabetes, microvascular complications, and cardiovascular complications: what is it about glucose? J Clin Invest 112:986-988.
54. Schwaninger RM, Sun H, and Mayhan WG (2003) Impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type II diabetic rats. Life Sci 73:3415-3425. (Pubitemid 37311381)
55. Sharma SS, Dhar A, and Kaundal RK (2007) FeTPPS protects against global cerebral ischemic-reperfusion injury in gerbils. Pharmacol Res 55:335-342. (Pubitemid 46518162)
56. Tiago T, Ramos S, Aureliano M, and Gutiérrez-Merino C (2006) Peroxynitrite induces F-actin depolymerization and blockade of myosin ATPase stimulation. Biochem Biophys Res Commun 342:44-49. (Pubitemid 43247357)
57. Turko IV and Murad F (2002) Protein nitration in cardiovascular diseases. Pharmacol Rev 54:619-634. (Pubitemid 35351199)
58. Williams DS, Detre JA, Leigh JS, and Koretsky AP (1992) Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci USA 89:212-216.
59. Zimmermann PA, Knot HJ, Stevenson AS, and Nelson MT (1997) Increased myogenic tone and diminished responsiveness to ATP-sensitive K+ channel openers in cerebral arteries from diabetic rats. Circ Res 81:996-1004. (Pubitemid 27514949)